Brief: Phathom Pharmaceuticals Announces Leadership Succession
01/04/2025 13:02
April 1 (Reuters) - Phathom Pharmaceuticals Inc PHAT.O: PHATHOM PHARMACEUTICALS ANNOUNCES LEADERSHIP SUCCESSION PHATHOM PHARMACEUTICALS INC - APPOINTS STEVEN BASTA AS PRESIDENT AND CEO PHATHOM PHARMACEUTICALS INC - TERRIE CURRAN STEPS DOWN AS PRESIDENT AND CEO OF PHATHOM PHARMACEUTICALS Source text: ID:nGNX3qnYY5 Further company coverage: PHAT.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates